Skip to content

To study the effectiveness of Haridra Dhooma Nasya(Turmeric Fume nasal inhalation) in Manyastambha(Cervical Spondylosis)

Study of efficacy of Haridra Dhooma Nasya (turmeric fume nasal inhalation) in the management of Manyastambha w.s.r to Cervical Spondylosis - an open clinical trial

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/05/042457
Enrollment
30
Registered
2022-05-11
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M479- Spondylosis, unspecified

Interventions

None listed

Sponsors

Parul Ayurved Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having classical signs and symptoms of Manyastambha. 2.Patients between age group of 18 to 60years. 3.Patients of either gender irrespective of caste and religion. 4.Patients fit for Dhooma Nasya Karma

Exclusion criteria

Exclusion criteria: 1.Subjects with uncontrolled metabolic disorders and other systemic disorders. 2.Subject having any cardiac complaints will be excluded. 3.H/o Fracture and dislocations of Neck. 4.H/o Injury to spinal nerves or spinal cord. 5.Involvement of debilitating neurological condition such as Paralysis, brachial palsy.etc 6.Subjects contraindicated for Nasya karma.

Design outcomes

Primary

MeasureTime frame
Helps in Reducing pain, stiffness, heaviness and numbness in cervical region.Timepoint: On 8th Day

Secondary

MeasureTime frame
Improvement in range of movement of Neck.Timepoint: on 15th Day

Countries

India

Contacts

Public ContactDr Dinesh Patil

Parul Ayurved Hospital

dr.dineshpatil3@gmail.com9039764509

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026